IL179642A0 - Polysaccharide derivatives and uses in induction of an immune response - Google Patents

Polysaccharide derivatives and uses in induction of an immune response

Info

Publication number
IL179642A0
IL179642A0 IL179642A IL17964206A IL179642A0 IL 179642 A0 IL179642 A0 IL 179642A0 IL 179642 A IL179642 A IL 179642A IL 17964206 A IL17964206 A IL 17964206A IL 179642 A0 IL179642 A0 IL 179642A0
Authority
IL
Israel
Prior art keywords
induction
immune response
polysaccharide derivatives
polysaccharide
derivatives
Prior art date
Application number
IL179642A
Other languages
English (en)
Original Assignee
Childrens Hospital & Res Ct At
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hospital & Res Ct At filed Critical Childrens Hospital & Res Ct At
Publication of IL179642A0 publication Critical patent/IL179642A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/36—Neisseria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL179642A 2004-06-23 2006-11-27 Polysaccharide derivatives and uses in induction of an immune response IL179642A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58267204P 2004-06-23 2004-06-23
PCT/US2005/022590 WO2006002402A2 (en) 2004-06-23 2005-06-23 Polysaccharide derivatives and uses in induction of an immune response

Publications (1)

Publication Number Publication Date
IL179642A0 true IL179642A0 (en) 2007-05-15

Family

ID=35782376

Family Applications (1)

Application Number Title Priority Date Filing Date
IL179642A IL179642A0 (en) 2004-06-23 2006-11-27 Polysaccharide derivatives and uses in induction of an immune response

Country Status (14)

Country Link
US (2) US7595307B2 (https=)
EP (1) EP1784428A2 (https=)
JP (1) JP2008509886A (https=)
KR (1) KR20070060069A (https=)
AU (1) AU2005258301A1 (https=)
BR (1) BRPI0512413A (https=)
CA (1) CA2568982A1 (https=)
CR (1) CR8862A (https=)
EC (1) ECSP077129A (https=)
IL (1) IL179642A0 (https=)
MX (1) MXPA06015107A (https=)
NO (1) NO20070434L (https=)
RU (1) RU2404995C2 (https=)
WO (1) WO2006002402A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8148335B2 (en) 2004-06-23 2012-04-03 Children's Hospital & Research Center Oakland De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
BRPI0512413A (pt) 2004-06-23 2008-03-04 Childrens Hosp & Res Ct Oak derivados de polissacarìdeo e usos na indução de uma resposta imune
CA2620416A1 (en) * 2005-08-24 2007-03-01 Novartis Vaccines And Diagnostics S.R.L. Zwitterionization of capsular saccharides
WO2007075921A2 (en) * 2005-12-23 2007-07-05 Children's Hospital & Research Center At Oakland De-n-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
CA2692069C (en) * 2007-06-20 2016-10-18 Baxter Healthcare S.A. Modified polysaccharides for conjugate vaccines
WO2009006620A1 (en) 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
AU2008272854B2 (en) * 2007-07-03 2014-03-13 Children's Hospital & Research Center At Oakland Inhibitors of polysialic acid de-N-acetylase and methods for using the same
WO2009006613A1 (en) 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
US20130116423A1 (en) 2010-04-23 2013-05-09 A. Stewart Campbell Synthetic Oligosaccharides for Staphylococcus Vaccine
US8716469B2 (en) 2010-04-27 2014-05-06 Ancora Pharmaceuticals, Inc. Synthetic oligosaccharides for Moraxella vaccine
WO2011149778A1 (en) 2010-05-26 2011-12-01 Ancora Pharmaceuticals Inc. Synthetic oligosaccharides for neisseria meningitis vaccine
CN109182423B (zh) * 2018-09-26 2020-07-07 武汉中科光谷绿色生物技术有限公司 促进大肠杆菌发酵生产聚唾液酸的方法
CN112795583A (zh) * 2020-11-16 2021-05-14 上海大学 重组唾液酸外切酶的制备方法、表达基因、重组表达载体及构建方法
CN114507262B (zh) * 2022-03-01 2023-12-19 德元堂(上海)健康科技发展有限公司 一种聚唾液酸的水解工艺
CN114539333B (zh) * 2022-03-01 2023-12-22 德元堂(上海)健康科技发展有限公司 一种唾液酸的循环生产工艺

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314999A (en) * 1978-07-31 1982-02-09 Proter S.P.A. N-Acyl derivatives of glucosamine having antitumor chemotherapeutic acitivity
US4216208A (en) * 1978-07-31 1980-08-05 Proter S.P.A. N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity
US4727136A (en) 1985-10-01 1988-02-23 Canadian Patents And Development Ltd. Modified meningococcal group B polysaccharide for conjugate vaccine
US4722136A (en) * 1985-10-28 1988-02-02 Leviton Manufacturing Company, Inc. Snap-in convenience electrical connector system and method of assembly
JPS6344590A (ja) * 1986-08-12 1988-02-25 Mect Corp シアル酸誘導体の製造方法
HU9201966D0 (en) 1989-12-14 1992-10-28 Ca Nat Research Council An improved vaccine of meningococcus-polysaccharide conjunction
US5846951A (en) * 1991-06-06 1998-12-08 The School Of Pharmacy, University Of London Pharmaceutical compositions
GB9116896D0 (en) * 1991-08-06 1991-09-18 Erba Carlo Spa 3-deoxymannosamine derivatives and process for their preparation
US5811102A (en) * 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
JPH101397A (ja) * 1996-06-14 1998-01-06 Mitsubishi Gas Chem Co Inc 磁気光学素子の基板用ガーネット結晶及びその製造法
JP4150082B2 (ja) * 1996-08-27 2008-09-17 カイロン コーポレイション 独特の髄膜炎菌性ｂエピトープを規定するモノクローナル抗体およびワクチン組成物の調製におけるそれらの使用
ES2166097T5 (es) * 1996-08-27 2007-03-16 Novartis Vaccines And Diagnostics, Inc. Glicoconjugados de neisseria meningitidis de serogrupo b y procedimientos para usarlos.
ATE421527T1 (de) 1997-08-27 2009-02-15 Novartis Vaccines & Diagnostic Molekular-mimetika von meningokokkus b epitopen
WO2000007602A1 (en) * 1998-08-06 2000-02-17 The Johns Hopkins University School Of Medicine Compounds for altering cell surface sialic acids and methods of use therefor
CA2279134A1 (en) * 1999-07-29 2001-01-29 Tianmin Liu Novel strategy for carbohydrate-based therapeutic vaccines
AU2001278323A1 (en) * 2000-07-28 2002-02-13 National Research Council Of Canada Modified sialic acid vaccines
BRPI0512413A (pt) 2004-06-23 2008-03-04 Childrens Hosp & Res Ct Oak derivados de polissacarìdeo e usos na indução de uma resposta imune

Also Published As

Publication number Publication date
MXPA06015107A (es) 2007-03-26
WO2006002402A3 (en) 2006-05-04
NO20070434L (no) 2007-03-20
US20100068728A1 (en) 2010-03-18
RU2404995C2 (ru) 2010-11-27
BRPI0512413A (pt) 2008-03-04
WO2006002402A2 (en) 2006-01-05
RU2007102255A (ru) 2008-07-27
US7595307B2 (en) 2009-09-29
CA2568982A1 (en) 2006-01-05
JP2008509886A (ja) 2008-04-03
KR20070060069A (ko) 2007-06-12
AU2005258301A1 (en) 2006-01-05
CR8862A (es) 2007-07-24
US20070010482A1 (en) 2007-01-11
EP1784428A2 (en) 2007-05-16
ECSP077129A (https=) 2007-02-28

Similar Documents

Publication Publication Date Title
IL179642A0 (en) Polysaccharide derivatives and uses in induction of an immune response
IL183458A0 (en) Anti-il-1r1 single domain antibodies and therapeutic uses
EP1968685A4 (en) METHOD AND APPARATUS FOR APPETIZING APPROACH AND / OR REDUCING FOOD RECEIPT
EP1843768A4 (en) SUBSTITUTED MORPHINANES AND METHODS OF USE
AU2003284808A8 (en) The derivatives of pyridone and the use of them
GB0313123D0 (en) Improvements in and relating to food preparation
ZA200607913B (en) Isoquinoline Derivatives and methods of use thereof
EP2026713A4 (en) Improvements in methods and devices to curb appetite and/or reduce food intake
AP2006003820A0 (en) Piperazin derivatives and their use in controllingpests
IL172826A0 (en) Quinoline derivates and their use in therapy
TWI350286B (en) Alkylpiperazine- and alkylhomopiperazine-carboxylate derivatives, their preparation and their application in therapy
DK3401327T3 (da) Genprodukter med forskellig ekspression i tumorer og anvendelser deraf
IL176769A0 (en) Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
IL176772A0 (en) Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors
EP1786965A4 (en) LAMINATED PRODUCTS AND METHODS OF PRODUCING THE SAME
IL179474A0 (en) Functional foods comprising flavonoids and tocotrienols and methods thereof
IL178888A0 (en) Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
GB2409265B8 (en) Improvements In and Relating to Stoves
GB0401182D0 (en) Improvements in and relating to conveyors
ZA200606216B (en) Modified human interferon polypeptides and their uses
IL180079A0 (en) Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus
FI20045395L (fi) Ravintoainelisä ja sen käyttö
EP1741193A4 (en) MINIMIZING THE DIFFERENTIAL DELAY IN ADSL2 AND ADSL2 + TO SUPPORT BONDING
HK1107824A (en) Use of cr1-binding molecules in clearance and induction of immune responses
IL176701A0 (en) Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics